Latest Clinical Papers
Additional nodules detected using EOB-MRI in patients with resectable single hepatocellular carcinoma: An implication for active treatment strategy
Aggressive treatment (resection/RFA) for additional nodules detected on EOB-MRI in HCC patients results in comparable long-term survival to that of solitary HCC cases.
2024
Prognostic value of baseline MRI features in patients treated with thermal ablation for hepatocellular carcinoma
Presence of peritumoral hypointensity on baseline hepatobiliary phase emerges as a predictor for the time-to-recurrence in early-stage hepatocellular carcinoma patients treated with thermal ablation.
2024
Hepatobiliary-phase (HBP) gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid MRI (Gd-EOB-DTPA) for pretreatment prediction of efficacy-to-standard-therapies based on Barcelona Clinic Liver Cancer algorithm: an up-todate review
The HBP in EOB-MRI reflecting molecular and pathological factors, may predict hepatocellular carcinoma (HCC) treatment efficacy and guide treatment choices.
2023
A multivariate model based on gadoxetic acidenhanced MRI using Li-RADS v2018 and other imaging features for preoperative prediction of dualphenotype hepatocellular carcinoma (DPHCC)
Gd-EOB-DTPA MRI effectively differentiates between DPHCC and non-DPHCC.
2023
Magnetic resonance imaging-based risk factors of hepatocellular carcinoma after direct-acting antiviral therapy: multicenter observational study
Gd-EOB-DTPA MRI could predict the development of hypervascular HCC following HCV DAA therapy.
2023
